| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/21/2008 | WO2007106476A3 Compositions and methods for enhancing the immunogenicity of antigens |
| 08/21/2008 | WO2007072022A3 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 08/21/2008 | WO2007063421A8 Compositions and methods relating to treatment of cancer and infectious diseases |
| 08/21/2008 | US20080200665 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine |
| 08/21/2008 | US20080200664 Nucleotide sequences coding transcription factor (p63) for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/21/2008 | US20080200653 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2008 | US20080200550 Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein |
| 08/21/2008 | US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder |
| 08/21/2008 | US20080200386 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/21/2008 | US20080200368 Peptide composition |
| 08/21/2008 | US20080199952 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity |
| 08/21/2008 | US20080199911 Producing water-soluble protein from chimeric water-insoluble via polypeptide refolding; preparing genetic vaccine for treatment and prevention of viral infection in animal; veterinary medicine |
| 08/21/2008 | US20080199531 Methods And Products For Delivering Biological Molecules To Cells Using Multicomponent Nanostructures |
| 08/21/2008 | US20080199514 Nucleotide polymorphism in gene coding; causing mutants; prevents binding; useful for diagnosis, therapy |
| 08/21/2008 | US20080199499 Method for Making Targeted Therapeutic Agents |
| 08/21/2008 | US20080199498 In situ administering Clostridium toxin; antiinflammatory agents |
| 08/21/2008 | US20080199497 Mixture with carrier; injecting into interior of knee |
| 08/21/2008 | US20080199495 Administering hematopoietic stem cells for activation of gland; improve immunology response to leutinizing hormone- releasing hormone; antitumor, anticancwer agents |
| 08/21/2008 | US20080199494 Vaccine |
| 08/21/2008 | US20080199493 cytomegalio viruses; herpes virus; maintenance high level of immunology response; therapy or prevention of infections; genetic engineered vector; gene expression of antigen or fusion protein |
| 08/21/2008 | US20080199492 Env Polypeptide Complexes and Methods Of Use |
| 08/21/2008 | US20080199491 vaccine containing antigen and non-liquid adjuvants ; implantable pellet, capsule, tablet, powder or aerosol |
| 08/21/2008 | US20080199490 Haemophilus influenzae type b (Hib) saccharide conjugates; serotypes; vaccine kits |
| 08/21/2008 | US20080199487 Such as (2S,3S,4R)-1-O-( alpha -D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol; kits |
| 08/21/2008 | US20080199486 Grp94-based compositions and methods of use thereof |
| 08/21/2008 | US20080199485 Method for enhancing T cell response |
| 08/21/2008 | US20080199484 Using cyclooxgenase inhibitor as antitumor therapeutic in treatment of cell proliferative disorders |
| 08/21/2008 | US20080199483 Long lasting fusion peptide inhibitors of viral infection |
| 08/21/2008 | US20080199482 Method For Inhibiting The Transendothelial Migration Of Cells Such As Leukocytes Or Tumor Cells By A Cd-Binding Substance And Uses Thereof |
| 08/21/2008 | US20080199481 B cell-attracting chemokine 1 specific immunoglobulin for use in treatment and prevention of rheumatoid arthritis |
| 08/21/2008 | US20080199480 Methods for Identifying Risk of Type II Diabetes and Treatments Thereof |
| 08/21/2008 | US20080199479 Method of treating a muscle-related condition with modified IGF1 polypeptides |
| 08/21/2008 | US20080199478 Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections |
| 08/21/2008 | US20080199477 Human receptor proteins; related reagents and methods |
| 08/21/2008 | US20080199476 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 08/21/2008 | US20080199475 Novel glycosylated peptide target in neoplastic cells |
| 08/21/2008 | US20080199474 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199472 Using secretory leukocyte protease inhibitor (SLPI) to identify modulators for treatment and prevention of tumor migration |
| 08/21/2008 | US20080199471 Optimized cd40 antibodies and methods of using the same |
| 08/21/2008 | US20080199470 Using serum granulin-epithelin precursor (GEP) concentrations as diagnostic indicator of hepatic tumor growth; immunodiagnostics; immunotherapy |
| 08/21/2008 | US20080199469 Using A20 binding inhibitor of NF- kappa B (ABIN) to stabilize MEK kinase and treat and/or prevent inflammatory diseases |
| 08/21/2008 | US20080199468 Method For Diagnosing Colorectal Cancers |
| 08/21/2008 | US20080199467 Immunoglobulin supergene fusion for use in treatment of vascular disorders |
| 08/21/2008 | US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders |
| 08/21/2008 | US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor |
| 08/21/2008 | US20080199464 Combination Therapy with Angiogenesis Inhibitors |
| 08/21/2008 | US20080199463 Method for treating multiple myeloma |
| 08/21/2008 | US20080199462 Preventing airway mucus production by administration of egf-r antagonists |
| 08/21/2008 | US20080199461 Using immunoglobulin which preferentially binds cancer specific antigen (OVR110) as treatment for head and neck or endometrial cancer |
| 08/21/2008 | US20080199460 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| 08/21/2008 | US20080199459 Mitotic Kinesin Inhibitors |
| 08/21/2008 | US20080199458 Therapeutic mixture comprising St. john's wort and preferential immunoglobulins for use in treatment of viral infections |
| 08/21/2008 | US20080199457 Tetraspanin specific immunoglobulin for use in treatment and prevention of allergic disorders; immunotherapy |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199455 Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| 08/21/2008 | US20080199424 Mart-1 t cell receptors |
| 08/21/2008 | US20080199423 Enhancing apoptosis or cytolytic activity using natural killer cells;ligand polypeptide; interleukins, interferons; anticarcinogen |
| 08/21/2008 | US20080199422 Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline |
| 08/21/2008 | US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines |
| 08/21/2008 | CA2678432A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | CA2678353A1 A method for enhancing t cell response |
| 08/21/2008 | CA2678181A1 Antibodies against erbb3 and uses thereof |
| 08/21/2008 | CA2677937A1 Use of sucrose to suppress mannitol-induced protein aggregation |
| 08/21/2008 | CA2677853A1 Allergen fragments |
| 08/21/2008 | CA2677782A1 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 08/21/2008 | CA2677748A1 Binding members for ige molecules |
| 08/21/2008 | CA2677597A1 Binding members for ige molecules |
| 08/21/2008 | CA2677383A1 Antibody library display by yeast cell plasma membrane |
| 08/21/2008 | CA2676766A1 Anti-robo4 antibodies and uses therefor |
| 08/21/2008 | CA2676719A1 Viral vectors and methods of use |
| 08/21/2008 | CA2676568A1 Prevention and treatment of sub-clinical pcvd |
| 08/21/2008 | CA2675602A1 Protein formulations containing sorbitol |
| 08/21/2008 | CA2675257A1 Hiv combination vaccine and prime boost method |
| 08/21/2008 | CA2664791A1 Recombinant rhinovirus vectors |
| 08/20/2008 | EP1959015A2 Secreted streptococcus pneumoniae proteins |
| 08/20/2008 | EP1959014A2 Antibodies against insulin-like growth factor I receptor and uses thereof |
| 08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
| 08/20/2008 | EP1959009A1 Genetically recombinant anti-perp antibody |
| 08/20/2008 | EP1958966A2 Methods for modulating T cell responses by manipulating a common cytokine receptor gamma chain |
| 08/20/2008 | EP1958965A2 Agonist antibodies to a musk receptor, and their therapeutic uses |
| 08/20/2008 | EP1958960A2 A process for the preparation of a non-toxic anthrax vaccine |
| 08/20/2008 | EP1958959A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 08/20/2008 | EP1958958A1 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 08/20/2008 | EP1958647A1 Pharmaceutical composition with bacteria for tumor treatment |
| 08/20/2008 | EP1958646A1 Dual carrier immunogenic construct |
| 08/20/2008 | EP1958645A1 Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof |
| 08/20/2008 | EP1958644A1 Prevention and treatment of sub-clinical pcvd |
| 08/20/2008 | EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 08/20/2008 | EP1957638A1 Uses of the fcrn receptor |
| 08/20/2008 | EP1957537A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 08/20/2008 | EP1957534A1 Therapeutic vaccines targeting hmgb1 |
| 08/20/2008 | EP1957530A2 Human antibodies against il13 and therapeutic uses |
| 08/20/2008 | EP1957520A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/20/2008 | EP1957115A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 08/20/2008 | EP1957108A1 Glioma-specific antibodies against behab/brevican for diagnostic and therapeutic applications |
| 08/20/2008 | EP1957107A2 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
| 08/20/2008 | EP1957105A2 Vaccines containing non-live antigenic vectors |
| 08/20/2008 | EP1957104A1 Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
| 08/20/2008 | EP1957103A2 Bacterial vaccine against bacterial infective agents, to be used in animals |